TANOX, INC.
🏢 View company profile →31Patents
3Active
31Granted
36Portfolio score
Filing activity: Sep 26, 1991 → Nov 7, 2013 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5908626A | Hybrid with interferon-.beta. and an immunoglobulin Fc joined by a peptide linker | Chemistry; Metallurgy | 126 | Expired |
| US6433155B1 | Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof | Chemistry; Metallurgy | 86 | Expired |
| US6956107B2 | Inhibitors of complement activation | Chemistry; Metallurgy | 58 | Expired |
| US6129916A | Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates | Emerging Cross-Sectional Technologies | 38 | Expired |
| US7112327B2 | Inhibition of complement activation | Chemistry; Metallurgy | 36 | Expired |
| US6534058B2 | Anti-C5 monoclonal antibodies | Human Necessities | 35 | Expired |
| US6197298A | Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals | Human Necessities | 33 | Expired |
| US7531169B2 | High affinity anti-human IgE antibodies | Emerging Cross-Sectional Technologies | 31 | Expired |
| US8252284B2 | High affinity, anti-human IgE antibodies | Emerging Cross-Sectional Technologies | 27 | Active |
| US8604171B2 | High affinity, anti-human IgE antibodies | Emerging Cross-Sectional Technologies | 26 | Active |
| US6117982A | Conjugates of microbeads and antibodies specific for T lymphocytes and their use as in vivo immune modulators | Human Necessities | 21 | Expired |
| US6436639B1 | Bak promoter expression system | Physics | 18 | Expired |
| US6998468B2 | Anti-C2/C2a inhibitors of complement activation | Chemistry; Metallurgy | 13 | Expired |
| US6106835A | Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators | Chemistry; Metallurgy | 11 | Expired |
| US5854400A | Monoclonal antibodies which neutralize HIV-1 infection | Chemistry; Metallurgy | 11 | Expired |
| US6177548A | Enhanced aggregate removal from bulk biologicals using ion exchange chromatography | Chemistry; Metallurgy | 10 | Expired |
| US7118743B2 | Bispecific molecules cross-linking ITIM and ITAM for therapy | Chemistry; Metallurgy | 8 | Expired |
| US6787524B2 | CpG oligonucleotides and related compounds for enhancing ADCC induced by anti-IgE antibodies | Human Necessities | 5 | Expired |
| US6586395B1 | Apoptosis-modulating proteins | Chemistry; Metallurgy | 5 | Expired |
| US7045596B2 | Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof | Chemistry; Metallurgy | 4 | Expired |
| US5981278A | Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS | Chemistry; Metallurgy | 4 | Expired |
| US6767540B2 | Use of antagonists of plasminogen activator inhibitor-1 (PAI-1) for the treatment of asthma and chronic obstructive pulmonary disease | Human Necessities | 2 | Expired |
| US6309880A | Antibodies specific for CD4-binding domain of HIV-1 | Chemistry; Metallurgy | 2 | Expired |
| US7045604B2 | Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof | Chemistry; Metallurgy | 1 | Expired |
| US6685930B1 | Methods and substances for recruiting therapeutic agents to solid tumors | Chemistry; Metallurgy | 1 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.